Tag:

Boston Scientific

Latest Headlines

Latest Headlines

Boston Scientific ordered to hand over $18.5M in vaginal mesh litigation

Less than a week after Boston Scientific lost its second courtroom battle over vaginal mesh implants, a federal jury ordered the company to pay $18.5 million in damages to four women who claimed the devices caused them constant pain and injuries.

Boston Scientific's Synergy Stent performs well in pivotal clinical trial

Boston Scientific's Synergy bioabsorbable polymer drug-eluting stent is on track for FDA approval after the successful Evolve II clinical trial, experts said, citing data released yesterday at the American Heart Association meeting in Chicago.

Boston Scientific and J&J gear up for courtroom showdown over Guidant purchase

Boston Scientific and Johnson & Johnson are gearing up for a courtroom showdown, as the companies prepare for a multibillion-dollar trial over a breach-of-contract suit related to a failed bidding war for devicemaker Guidant.

Boston Scientific ordered to fork over $27.6M in vaginal mesh suit

Boston Scientific faced a stinging setback in its ongoing vaginal mesh litigation as a federal court jury ordered the company to pay $26.7 million to four women who claimed the devices caused them undue pain and suffering.

Former Boston Scientific engineer charged with intellectual theft

A former Boston Scientific engineer has been indicted by a federal grand jury for stealing documents from the giant device maker that he allegedly planned to use to set up a manufacturing business in Vietnam and market the products in the U.S. and elsewhere under a new name.

Boston Scientific faces first two federal trials for transvaginal mesh devices

Boston Scientific is shoring up for the first federal trials over its transvaginal mesh devices, countering claims from women who say the products were faulty and caused them injury.

Boston Scientific upbeat on Watchman approval for 1H15, pegs 'conservative' $500M market

Boston Scientific expects an FDA approval of its controversial stroke-fighting device Watchman during the first half of next year coming off its third positive FDA panel, despite a checkered regulatory past that includes a 2010 rejection due to safety concerns.

Boston Scientific wins CE mark for MRI-friendly pacemaker products

Boston Scientific won CE-mark approval for a new suite of MRI-friendly pacemaker products, boosting its product offerings and furthering its plan of revitalizing sales for its sluggish cardiac unit.

Boston Scientific wins positive recommendation from FDA panel for stroke-fighting Watchman device

Boston Scientific won a positive recommendation from an FDA panel for its stroke-fighting Watchman device, even as panel members expressed doubt that the product would work well in patients who are eligible for traditional drug therapy.

Preview: Boston Scientific's Watchman goes before third FDA panel

The long slog toward approval for Boston Scientific's Watchman implant continues today when it goes before a FDA advisory panel for a third time.